(Q51324113)

3 April 2018

title

Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome. (English)

1 reference

3 April 2018

polycystic ovary syndrome

1 reference

1 reference

1 reference

1 reference

1 reference

ORCID Public Data File 2021

author name string

Kadriye Aydin

1

1 reference

3 April 2018

Gulcan Arusoglu

2

1 reference

3 April 2018

Gulden Koksal

3

1 reference

3 April 2018

Nese Cinar

4

1 reference

3 April 2018

Duygu Yazgan Aksoy

5

1 reference

3 April 2018

Bulent O Yildiz

6

1 reference

3 April 2018

publication date

19 May 2014

1 reference

3 April 2018

published in

Clinical Endocrinology

1 reference

3 April 2018

volume

81

1 reference

3 April 2018

issue

4

1 reference

3 April 2018

page(s)

588-592

1 reference

3 April 2018

Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.

cites work

1 reference

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

21 January 2018

1 reference

Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose tolerance.

21 January 2018

1 reference

Incretin levels in polycystic ovary syndrome.

21 January 2018

1 reference

Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin

21 January 2018

1 reference

Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

21 January 2018

1 reference

Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment

21 January 2018

1 reference

Estradiol increases body weight loss and gut-peptide satiation after Roux-en-Y gastric bypass in ovariectomized rats

21 January 2018

1 reference

Activation of enteroendocrine membrane progesterone receptors promotes incretin secretion and improves glucose tolerance in mice

21 January 2018

1 reference

Effect of hormone therapy on the enteroinsular axis

21 January 2018

1 reference

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

Increased circulating soluble P-selectin in polycystic ovary syndrome.

21 January 2018

1 reference

Visually scoring hirsutism

21 January 2018

1 reference

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

Diagnosis of hyperandrogenism: biochemical criteria

21 January 2018

1 reference

Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS.

21 January 2018

1 reference

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

21 January 2018

1 reference

Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance

21 January 2018

1 reference

The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.12468

1 reference

3 April 2018

PubMed ID

24730585

1 reference

3 April 2018